SEARCH

SEARCH BY CITATION

References

  • 1
    Joenje H. Genetic toxicology of oxygen. Mutat Res 1989; 219: 193208.
  • 2
    Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227: 37581.
  • 3
    Rojas E, Valverde M, Sordo M, Ostrosky-Wegman P. DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat Res 1996; 370: 11520.
  • 4
    Bohm F, Edge R, McGarvey DJ, Truscott TG. β-carotene with vitamins E and C offers synergistic cell protection against NOx. FEBS Lett 1998; 436: 3879.
  • 5
    Bohm F. Carotenoids enhance vitamin E antioxidant efficiency. J Am Chem Soc 1997; 119: 6212.
  • 6
    Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 1996; 56: 12915.
  • 7
    Kim Y, Chongviriyaphan N, Liu C, Russell RM, Wang XD. Combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model. Carcinogenesis 2006; 27: 141019.
  • 8
    Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 147289.
  • 9
    Jerome L, Shiry L, Leyland-Jones B. Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocr Relat Cancer 2003; 10: 56178.
  • 10
    Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 1999; 51 (Suppl. 3): 3441.
  • 11
    Rechler MM. Growth inhibition by insulin-like growth factor (IGF) binding protein-3—what's IGF got to do with it? Endocrinology 1997; 138: 26457.
  • 12
    Strom SS, Wu S, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG, Spitz MR. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr 1995: 2933.
  • 13
    Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 1997; 138: 176770.
  • 14
    Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 2000; 275: 3360713.
  • 15
    Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993; 268: 1496471.
  • 16
    Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997; 272: 121818.
  • 17
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res 1996; 56: 154550.
  • 18
    Huynh H, Pollak M, Zhang JC. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. Int J Oncol 1998; 13: 13743.
  • 19
    Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001; 98: 103505.
  • 20
    Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001; 87: 81420.
  • 21
    Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002; 11: 85261.
  • 22
    Liu C, Lian F, Smith DE, Russell RM, Wang XD. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003; 63: 313844.
  • 23
    Wang XD, Krinsky NI, Marini RP, Tang G, Yu J, Hurley R, Fox JG, Russell RM. Intestinal uptake and lymphatic absorption of β-carotene in ferrets: a model for human β-carotene metabolism. Am J Physiol 1992; 263: G4806.
  • 24
    Gugger ET, Bierer TL, Henze TM, White WS, Erdman JW,Jr. β-carotene uptake and tissue distribution in ferrets (Mustela putorius furo). J Nutr 1992; 122: 1159.
  • 25
    Wang XD, Russell RM, Liu C, Stickel F, Smith DE, Krinsky NI. β-oxidation in rabbit liver in vitro and in the perfused ferret liver contributes to retinoic acid biosynthesis from β-apocarotenoic acids. J Biol Chem 1996; 271: 264908.
  • 26
    Liu C, Russell RM, Wang XD. α-tocopherol and ascorbic acid decrease the production of β-apo-carotenals and increase the formation of retinoids from β-carotene in the lung tissues of cigarette smoke-exposed ferrets in vitro. J Nutr 2004; 134: 42630.
  • 27
    Hu KQ, Liu C, Ernst H, Krinsky NI, Russell RM, Wang XD. The biochemical characterization of ferret carotene-9′,10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J Biol Chem 2006; 281: 1932738.
  • 28
    Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91: 606.
  • 29
    Kim Y, Liu XS, Liu C, Smith DE, Russell RM, Wang X-D. Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): a model for human lung cancer. Cancer Lett 2006; 234: 20919.
  • 30
    Erdman JW,Jr, Thatcher AJ, Hofmann NE, Lederman JD, Block SS, Lee CM, Mokady S. All-trans β-carotene is absorbed preferentially to 9-cis β-carotene, but the latter accumulates in the tissues of domestic ferrets (Mustela putorius puro). J Nutr 1998; 128: 200913.
  • 31
    Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, Thompson C, Pedrosa MC, Diamond RD, Stollar BD. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 1997; 277: 13806.
  • 32
    Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 1995; 15: 1908.
  • 33
    Princen HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Gevers Leuven JA, van Hinsbergh VW. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995; 15: 32533.
  • 34
    McKay DL, Perrone G, Rasmussen H, Dallal G, Hartman W, Cao G, Prior RL, Roubenoff R, Blumberg JB. The effects of a multivitamin/mineral supplement on micronutrient status, antioxidant capacity and cytokine production in healthy older adults consuming a fortified diet. J Am Coll Nutr 2000; 19: 61321.
  • 35
    Yeum KJ, Taylor A, Tang G, Russell RM. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest Ophthalmol Vis Sci 1995; 36: 275661.
  • 36
    Aldini G, Yeum KJ, Russell RM, Krinsky NI. A method to measure the oxidizability of both the aqueous and lipid compartments of plasma. Free Radic Biol Med 2001; 31: 104350.
  • 37
    Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 1996; 104(Suppl. 3): 4659.
  • 38
    Collins A, Dusinska M, Franklin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K, Vaughan N. Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 1997; 30: 13946.
  • 39
    Collins AR, Ma AG, Duthie SJ. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutat Res 1995; 336: 6977.
  • 40
    Chan AC. Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 1993; 71: 72531.
  • 41
    Black HS. Radical interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer 1998; 31: 2127.
  • 42
    The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. The α-Tocopherol, β Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 102935.
  • 43
    Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999; 69: 1086107.
  • 44
    Henning SM, Zhang JZ, McKee RW, Swendseid ME, Jacob RA. Glutathione blood levels and other oxidant defense indices in men fed diets low in vitamin C. J Nutr 1991; 121: 196975.
  • 45
    Lykkesfeldt J, Prieme H, Loft S, Poulsen HE. Effect of smoking cessation on plasma ascorbic acid concentration. BMJ 1996; 313: 91.
  • 46
    Cross CE, Halliwell B. Nutrition and human disease: how much extra vitamin C might smokers need? Lancet 1993; 341: 1091.
  • 47
    Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 1997; 65: 95963.
  • 48
    McLain DE, Thomas JA, Fox JG. Nutrition. In: FoxJG, ed. Biology and diseases of the ferreted. Philadelphia: Lea & Febiger, 1988. 13552.
  • 49
    Fiala ES, Sohn OS, Wang CX, Seibert E, Tsurutani J, Dennis PA, El-Bayoumy K, Sodum RS, Desai D, Reinhardt J, Aliaga C. Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E. Carcinogenesis 2005; 26: 60512.
  • 50
    Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999; 91: 1516.
  • 51
    London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK, Yu MC. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst 2002; 94: 74954.
  • 52
    Wakai K, Ito Y, Suzuki K, Tamakoshi A, Seki N, Ando M, Ozasa K, Watanabe Y, Kondo T, Nishino Y, Ohno Y. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. Jpn J Cancer Res 2002; 93: 127986.
  • 53
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Clin Cancer Res 2002; 8: 3796802.
  • 54
    Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 2002; 62: 35307.
  • 55
    Renehan AG, Atkin WS, O'Dwyer ST, Shalet SM. The effect of cigarette smoking use and cessation on serum insulin-like growth factors. Br J Cancer 2004; 91: 152531.
  • 56
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the β-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev 2002; 11: 141318.
  • 57
    Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 1998; 47: 11120.
  • 58
    Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998; 90: 9115.